Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel W Cramer

Showing results (131-140 of 233) with videos related to

Pageof 24
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Cancer Science|July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytomaOzge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
International Journal of Cancer|August 24, 2017
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association ConsortiumAna Babic, Holly R Harris, Allison F Vitonis, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Cancer Causes & Control : CCC|September 11, 2012
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association ConsortiumElizabeth M Poole, Margaret A Gates, Brigit A High, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
BMC Cancer|January 24, 2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association ConsortiumLinda E Kelemen, Elisa V Bandera, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Pageof 24

Showing results (131-140 of 233) with videos related to

Sort By:
Pageof 24
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimensDaniel W Cramer, Robert C Bast, Christine D Berg, et al.
Cancer Science|July 15, 2009
Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytomaOzge Alper, William G Stetler-Stevenson, Lyndsay N Harris, et al.
International Journal of Cancer|August 24, 2017
Menstrual pain and risk of epithelial ovarian cancer: Results from the Ovarian Cancer Association ConsortiumAna Babic, Holly R Harris, Allison F Vitonis, et al.
Fertility and Sterility|October 1, 2022
Effects of risk factors for ovarian cancer in women with and without endometriosisMinh Tung Phung, Aruna Muthukumar, Britton Trabert, et al.
Cancer Causes & Control : CCC|September 11, 2012
ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association ConsortiumElizabeth M Poole, Margaret A Gates, Brigit A High, et al.
Cancer Science|December 17, 2017
Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association ConsortiumTomotaka Ugai, Linda E Kelemen, Mika Mizuno, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
BMC Cancer|January 24, 2013
Recent alcohol consumption and risk of incident ovarian carcinoma: a pooled analysis of 5,342 cases and 10,358 controls from the Ovarian Cancer Association ConsortiumLinda E Kelemen, Elisa V Bandera, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 26, 2025
Patterns of Associations with Epidemiologic Factors by High-Grade Serous Ovarian Cancer Gene Expression SubtypesLindsay J Collin, Kara L Cushing-Haugen, Kathryn L Terry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 17, 2017
Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association ConsortiumHolly R Harris, Ana Babic, Penelope M Webb, et al.
Pageof 24